Eitan Konstantino, PhD
President & CEO, Co-Founder
Prior to co-founding TMI, Dr. Konstantino was co-founder, president and chief scientist of AngioScore Inc from its inception until 2006. Dr. Konstantino is the primary inventor of the AngioSculpt catheter and the Easy Exchange delivery system. Previously, Dr. Konstantino was the CEO & COO of Advanced Stent Technologies (AST), a bifurcation stent company that was acquired by Boston Scientific in 2004. He co-invented the Petal bifurcation stent that is currently in development at Boston Scientific. Prior to AST, he was Chief Technical Officer of Bypass Ltd, a developer of nitinol anastomotic devices for minimally invasive heart surgery. Dr. Konstantino received his PhD from Technion, Israel's premier engineering school. He currently serves as the co-chairman of the ASTM F04.30.06 Cardiovascular Standards Task Group.
Christopher Haig
Vice President of Marketing, Business Development, and International Sales
Mr. Haig brings over 20 years of US, European, and Asian experience in mature and early stage healthcare companies. His track record includes numerous successful product launches and pioneering commercialization and market development efforts in various fields such oral contraceptives, angioplasty devices, healthcare information, and radiation oncology. Prior to joining TMI in January of 2009, Mr. Haig was the VP, Marketing and Business Development with Calypso Medical Technologies, a privately held medical device company focused on improving the accuracy of external beam radiation therapy for cancer. Prior to joining Calypso, he spent 15 years in various marketing and business development roles of increasing responsibility with Guidant and Abbott Vascular. Most recently, Mr. Haig was the Director of Global Marketing for Drug Eluting Stents, which included responsibility for products such as Xience V and the next generation workhorse, bifurcation, and bioabsorbable stents. He earned an MBA from the Kenan-Flagler School of Business at the University of North Carolina and BA from the University of California at Berkeley.
Lian X. Cunningham, MD, PhD
Vice President of Clinical Affairs, Medical Director
Dr. Cunningham brings with her a wealth of experience in vascular surgery as both a practicing surgeon and science researcher. Prior to joining TMI, she served as a medical director and vice president of clinical research and education for VNUS Medical Technologies, where she oversaw worldwide registry and clinical trial programs. Dr. Cunningham came to the medical device industry from academic posts at Loyola University in Chicago and the Huaiyin Health School in Huaiyin, Jiangsu Province, China. In addition, she served as attending surgeon in the department of vascular surgery of the Shanghai Ninth Hospital and Shanghai Second Medical University in China, where she also completed her PhD training. Dr. Cunningham is the recipient of several international awards and honors and has published numerous book chapters as well as reviews and research articles in peer-reviewed literature.
Maria Pizarro, PMP
Vice President of Research and Development
Ms. Pizarro brings over 20 years of industry experience developing and manufacturing high technology products as well as medical devices. Her early career experience involved working at various aerospace companies: Hughes Aircraft (Raytheon), TRW, Loral-Librascope, and Eaton Corporation. Ms. Pizarro spent 10 years at Boston Scientific, Neurovascular Division, where she led neurovascular minimally invasive device research (intracranial implantable devices) and development projects from concept to commercialization. Prior to joining TMI, Ms. Pizarro was the Director of Research and Development at AngioScore Inc., where she led the development of cardiovascular and peripheral devices. A certified project manager, Ms. Pizarro obtained her Bachelor of Science degree from Texas A&M University and continued her post-graduate studies at UCLA.
Shiva Ardakani
Vice President of Regulatory and Quality
Ms. Ardakani brings with her 20 years of regulatory and quality experience in medical device startups and a solid track record in successful companies. Prior to joining TMI, Ms. Ardakani was Vice President of Regulatory, Quality and Clinical at Tenaxis, a company that produces vascular sealants for surgical hemostasis. Prior to Tenaxis, she held Director of Regulatory and Quality positions with EndoTex Interventional Systems and Advanced Stent Technologies (AST), both acquired by Boston Scientific. Ms. Ardakani was responsible for obtaining ISO Certification and CE marking for AST, EndoTex, and Tenaxis products. Previously, she held key quality management positions at ORATEC Interventions (acquired by Smith & Nephew), Micrus Fidus Medical Technology, and Fusion Medical Technologies (acquired by Baxter). In addition, she was instrumental in developing and managing the Quality Engineering and Quality Control departments. Ms. Ardakani has been published in numerous medical journals, holds a BS in Physics from San Jose State University, and is currently a member of the Regulatory Affairs Professionals Society.
Tanhum Feld
Chief Designer, Co-Founder
Mr. Feld is the primary inventor of the Antares™ stent. Prior to starting TMI, Mr. Feld was a co-founder at AngioScore Inc. Mr. Feld is co-inventor and chief designer of the AngioSculpt scoring balloon catheter. Prior to AngioScore, Mr. Feld served as the Director of Research and Development in Advanced Stent Technologies (AST) and co-invented the Petal bifurcation stent. Prior to AST, Mr. Feld held engineering positions at Bypass Ltd designing anastomotic devices for minimally invasive heart surgery and Evrica LTD designing various mechanical systems. He received his BS in Mechanical Engineering from the Technion, Israel Institute of Technology, in Haifa, Israel.